Avanir Joins Decentralized Trials & Research Alliance (DTRA) as a Founding Member to Advance Access to Clinical Trials
Global Industry Coalition Aims to Dramatically Increase Access for All Patient Populations in Clinical Trials and Research
News provided by
Share this article
Avanir Pharmaceuticals, Inc. (PRNewsFoto/Avanir Pharmaceuticals, Inc.)
ALISO VIEJO, Calif., April 19, 2021 /PRNewswire/ Avanir Pharmaceuticals, Inc. has joined the Decentralized Trial Research Alliance (DTRA), a recently launched coalition of 90 life sciences and healthcare organizations, as a founding member. DTRA is uniting industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical-trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.